Dated disclosed rounds · latest 2026-01-01
Later stage / growth
Nuclera
Synthetic biology / protein & antibody engineering hardware
VerifiedSeries CCambridge
- Companies House
- 08663936
- GLEIF LEI
- 549300LCIWHAVWEHOL50
- Latest evidence
- 2026-01-01
- Evidence snapshot
- 2026-08-25
Exact award notices · latest No exact award match
2026-08-01
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
6 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
FundingSource fact Series C extension
$12M additional (Series C total $87M) · 4 named investors
IdentifierReference metadata LEI record updated
549300LCIWHAVWEHOL50 · registration ISSUED
FundingSource fact Series C
$75M · 9 named investors
IdentifierReference metadata LEI first registered
549300LCIWHAVWEHOL50
RegistryRegistry fact Company incorporated
NUCLERA LTD · company 08663936
Latest disclosed round
Series C
- Date
- 2026-01-01
- Amount
- USD 87m
- Sector
- Biotech & techbio
- Companies House
- 08663936
- ONS region
- East
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Growth Network, Live Chris T D1
Capital network
5 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
Elevage Medical TechnologiesleadJonathan MilnerleadBritish Business BankparticipantCambridge Innovation CapitalparticipantGK Gohparticipant
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| Elevage Medical Technologies | lead | 2026-01-01 | Nuclera ↗ · Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Jonathan Milner | lead | 2026-01-01 | Nuclera ↗ · Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| British Business Bank | participant | 2026-01-01 | Nuclera ↗ · Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Cambridge Innovation Capital | participant | 2026-01-01 | Nuclera ↗ · Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| GK Goh | participant | 2026-01-01 | Nuclera ↗ · Vc ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Funding record
2 disclosed rounds
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2026-01-13 | Series C extension | $12M additional (Series C total $87M) | Elevage Medical Technologies · Jonathan Milner · British Patient Capital · GK Goh | Nuclera ↗ |
| 2024-10-16 | Series C | $75M | Elevage Medical Technologies · British Patient Capital · Cambridge Innovation Capital · GK Goh · M&G Catalyst · Verve Ventures · 3 additional source-listed names | Nuclera ↗ · Vc ↗ |
Companies House status and filing snapshot
NUCLERA LTD
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2013-08-27
- Dissolved
- Not applicable
- Company number
- 08663936
Filing context
- Accounts category
- GROUP
- Accounts made up to
- 2024-12-31
- Next accounts due
- 2026-09-30
- Confirmation made up to
- 2025-08-27
- Registry snapshot
- 2026-08-01
- Live check
- Bulk snapshot only
Former registered names: NUCLERA NUCLEICS LTD
72110Research and experimental development on biotechnology
Global legal-entity identifier
549300LCIWHAVWEHOL50
Exact company-number match to the GLEIF golden-copy data. An LEI is an identifier for a legal entity; it is not a credit, risk or investment-quality rating.
GLEIF record
- Legal name
- NUCLERA LTD
- Entity status
- ACTIVE
- Jurisdiction
- GB
- Registration status
- ISSUED
- Last updated
- 2025-11-29T12:10:57+00:00
- Next renewal
- 2027-01-26T20:18:34+00:00
Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.